GDP And Population Size – Important Determinants of Schizophrenia-Related Healthcare Costs In The European Countries

Schizophrenia is one of the most important public health issues in psychiatry. This review aims to explore the total direct healthcare cost of schizophrenia in European countries and associations of disease-related expenditures with economic performance (total GDP) and population size. A systematic literature search was conducted in compliance with the PRISMA Statement. The literature search was performed in January 2017 using MEDLINE, EMBASE...